CTT Pharmaceuticals

CTT Pharmaceutical Holdings, Inc. is dedicated to the development of innovative oral drug delivery systems, primarily targeting pain management and treatment. The company specializes in fast dissolving drug delivery systems, utilizing advanced oral delivery thin wafers infused with natural and/or synthetic cannabis extracts. This technology provides an alternative to traditional methods of smoking and ingestion, allowing for a more efficient and user-friendly treatment option. CTT's principal asset is a patented orally administered wafer composed of at least one physiologically acceptable film-forming agent. Based in Ottawa, Canada, the company was previously known as Mindesta Inc. before rebranding in July 2015.